 The investigators hypothesize that, following estrogen treatment of hypoestrogenic women with OAB, symptom improvement will be associated with 1 reduced FUM diversity, 2 alteration of other FUM characteristics and 3 increased AMP levels. The investigators propose two specific aims: 